Baxter International | BAX - Debt


Baxter International reported $9.78B in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
Abbott USD 34.05B 20.19B Mar/2026
AngioDynamics USD 6.3M 6.3M Feb/2025
Artivion USD 317.78M 619K Dec/2024
AtriCure USD 73.38M 3.35M Dec/2025
Avanos Medical USD 129.1M 4.6M Dec/2025
Baxter International USD 9.78B 68M Dec/2025
Becton, Dickinson and Co. USD 19.54B 358M Dec/2025
Boston Scientific USD 11.44B 610M Dec/2025
Cooper Companies USD 2.5B 5.6M Dec/2025
Dexcom USD 1.24B 900K Mar/2026
Edwards Lifesciences USD 600M 105.4M Mar/2026
Fresenius EUR 11.93B 919M Dec/2025
Globus Medical USD 118.66M 687K Dec/2025
Halozyme Therapeutics USD 2.14B 2.01M Mar/2026
ICU Medical USD 1.28B 79.88M Dec/2025
Inogen USD 0 0 Jun/2022
Insulet USD 949.2M 65.6M Dec/2025
Integra LifeSciences USD 2.04B 6.27M Mar/2026
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 54.99B 7.05B Mar/2026
Laboratory Of America USD 6.53B 3.9M Dec/2025
Medtronic USD 28.07B 1.03B Dec/2025
Merit Medical Systems USD 821.57M 420K Dec/2025
Quest Diagnostics USD 6.41B 179M Mar/2026
Smith & Nephew USD 3.32B 334M Dec/2024
Stryker USD 14.22B 635M Mar/2026
Tandem Diabetes Care USD 444.48M 4.81M Dec/2025
Teleflex USD 2.73B 43.5M Dec/2025
Terumo JPY 159.87B 14.97B Sep/2025
Zimmer Biomet Holdings USD 7.47B 48.1M Mar/2026